Related Experiment Videos
Pravastatin-induced lichenoid drug eruption
G C Keough1, T T Richardson, W J Grabski
1Department of Dermatology, Brooke Army Medical Center, Fort Sam Houston, Texas 78234-6200, USA.
Cutis
|March 27, 1998
Summary
Lichenoid drug eruptions are rare adverse effects of statin medications. This case study details a patient who experienced a recurring lichenoid eruption linked to pravastatin therapy.
Area of Science:
- Dermatology
- Pharmacology
- Internal Medicine
Background:
- Drug eruptions are known adverse reactions to various medications, including statins.
- Lichenoid eruptions, a specific type of skin reaction, are infrequently reported with statin use.
Observation:
- A patient developed characteristic lichenoid lesions after starting pravastatin.
- The skin lesions resolved upon discontinuation of pravastatin.
- The lichenoid eruption recurred when the patient was rechallenged with pravastatin.
Findings:
- This case highlights a rare instance of a lichenoid drug eruption associated with pravastatin.
- The temporal relationship between pravastatin use and the eruption suggests a causal link.
- Rechallenge confirmed pravastatin as the likely causative agent.
Implications:
- Clinicians should consider pravastatin as a potential cause of lichenoid eruptions in patients presenting with these lesions.
- This report contributes to the understanding of rare adverse skin reactions associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
- Further investigation into the mechanisms of statin-induced lichenoid drug eruptions may be warranted.